Best Birth Control Options for PCOS and Weight Control

Struggling with PCOS symptoms and weight management? Birth control can help. Certain contraceptives not only regulate hormones but also address PCOS-related issues like irregular periods, acne, and weight concerns. Here's a quick rundown of the best options:

• Fourth-Generation Pills (e.g., Drospirenone-based): May help with bloating and androgen levels but carry a slightly higher risk of blood clots.
• EE/CPA (Ethinyl Estradiol + Cyproterone Acetate): Effective for severe acne and hirsutism but has a higher risk of blood clots.
• Progestin-Only Pills (POPs): Safe for those avoiding estrogen; drospirenone-only pills offer anti-androgen benefits.
• Third-Generation Pills (e.g., Desogestrel-based): Weight-neutral and effective for acne and hair growth issues.

Each option has unique benefits and risks. Consult a healthcare provider to choose the one that aligns with your health and lifestyle goals.

The Birth Control Pill for PCOS | Weight loss + Menstrual Cycle (IS THIS MY ONLY OPTION?)

1. Fourth-Generation Combined Oral Contraceptive Pills (COCPs)

Fourth-generation COCPs incorporate newer progestins like drospirenone, dienogest, nomegestrol acetate, and norgestimate. These formulations are designed to reduce androgenic side effects, offering benefits for women managing PCOS.

Effects on Weight/BMI

Studies indicate that these COCPs may have a modest impact on lowering BMI. For instance, one study found a mean BMI reduction of 1.17 kg/m² (95% CI, 0.33–2.02) when compared to third-generation options. However, the connection between these contraceptives and body composition is more nuanced. In a study involving 28 lean women with PCOS and hyperandrogenism, the use of ethinyl estradiol/drospirenone over six months led to increases in total and truncal fat percentages, despite no changes in BMI, waist circumference, or waist-to-hip ratio. A larger retrospective study of 1,297 women with PCOS (mean age 28 years) found no significant differences in body measurements among current, past, and non-users of combined oral contraceptives. Beyond weight considerations, these pills are effective in managing androgen levels.

Androgenic Symptom Control

These contraceptives play a key role in controlling androgenic symptoms by raising sex hormone-binding globulin (SHBG) levels, which helps reduce free androgen levels in the bloodstream. Drospirenone offers anti-androgenic effects at about one-third the strength of cyproterone acetate, while dienogest provides about 40% of that potency. For issues like hirsutism, a treatment period of at least six months is typically recommended to assess the full effects.

Suitability for Metabolic Risk Profiles

Fourth-generation COCPs also bring metabolic advantages for women with PCOS. Drospirenone, for example, has anti-mineralocorticoid properties that may alleviate estrogen-related bloating, lower blood pressure, and improve HDL-C levels. Research shows that drospirenone-containing contraceptives can enhance HDL-C without increasing insulin resistance. Additionally, certain progestins like chlormadinone acetate may further support anti-androgenic effects by boosting SHBG levels and inhibiting 5-α reductase activity. Drospirenone stands out with a high bioavailability of approximately 76%.

Common Side Effects

While generally well-tolerated, fourth-generation COCPs are associated with some risks. For example, combinations containing drospirenone have been linked to a higher risk of venous thromboembolism (VTE) compared to those with levonorgestrel. Other common side effects include nausea, breast tenderness, mood changes, and occasional breakthrough bleeding, particularly during the initial months of use. Since individual reactions can vary, it’s crucial for women with PCOS to consult a healthcare provider experienced in PCOS management to determine the most suitable treatment plan.

2. Ethinyl Estradiol/Cyproterone Acetate (EE/CPA)

Ethinyl estradiol combined with cyproterone acetate (EE/CPA) is specifically designed for women dealing with pronounced hyperandrogenism, particularly those with polycystic ovary syndrome (PCOS). This combination - 2 mg of cyproterone acetate and 35 μg of ethinylestradiol - provides strong anti-androgenic effects, making it effective for managing PCOS-related skin and hair symptoms.

Androgenic Symptom Control

EE/CPA is especially effective for treating moderate to severe acne and hirsutism caused by androgen sensitivity in women of reproductive age.

"Polycystic ovary-related hyperandrogenic skin symptoms are effectively treated by CPA/EE, reducing both the symptoms and their impact on quality of life and mental health."

Clinical studies back up these claims. Research shows an 81% reduction in the free androgen index and a 639% increase in sex hormone-binding globulin levels among women treated with EE/CPA. In a randomized trial involving 60 overweight women with PCOS (conducted between July 2017 and April 2021), those treated with CPA/EE plus metformin saw significant reductions in hyperandrogenemia markers, including total testosterone, luteinizing hormone (LH), and the LH/FSH ratio.

Effects on Weight/BMI

While EE/CPA is effective for reducing androgen levels, it offers limited benefits for weight management. In a 12-week trial, participants in the CPA/EE plus metformin group showed no significant changes in weight or BMI (P > 0.05). On average, they experienced a modest weight loss of 1.85 ± 3.25 kg and a BMI decrease of 0.76 ± 1.31 kg/m². This result contrasts with other treatments more focused on metabolic improvements, which achieved weight reductions of around 7.40 kg during the same period.

Suitability for Metabolic Risk Profiles

EE/CPA has a mixed metabolic profile, which is an important consideration for women with PCOS, particularly those with pre-existing metabolic risks. Some benefits include improved lipid profiles, such as a 14% reduction in low-density lipoprotein (LDL) cholesterol, a 23% increase in HDL cholesterol, and a 19% drop in the total cholesterol/HDL cholesterol ratio. However, carbohydrate metabolism remains largely unaffected.

On the downside, EE/CPA is associated with an 82% increase in triglycerides and carries a higher risk of venous thromboembolism (VTE). These factors necessitate a thorough evaluation of each patient’s metabolic and cardiovascular risk before starting treatment.

Common Side Effects

The most serious concern with EE/CPA is its increased risk of blood clots. Health Canada highlights that this treatment should not be prescribed to individuals with a history of thromboembolic events or other risk factors such as advanced age, smoking, obesity, hereditary thrombophilia, cardiac disease, prior thromboembolic episodes, or prolonged immobility.

According to Health Canada:

"The drug's benefits continue to outweigh its risks, when used as authorized... is approved for the temporary treatment of severe acne - with associated symptoms of high levels of male hormones... in women who are unresponsive to other available treatments. It should not be used in patients with a history that puts them at risk for blood clots, and is not approved for use as an oral contraceptive."

Given these risks, many healthcare providers are reassessing the use of EE/CPA, particularly for off-label purposes. Safer alternatives are available for contraception and the treatment of mild to moderate acne. For women with PCOS, EE/CPA may be most suitable when severe androgenic symptoms are the main concern, provided their metabolic risks are carefully managed.

3. Progestin-Only Pills (POPs)

Progestin-only pills (POPs) are a hormone-based contraceptive option that completely excludes estrogen. This makes them a safer choice for women with PCOS who have cardiovascular risks or prefer to avoid estrogen exposure. POPs work by thickening cervical mucus, suppressing ovulation, and thinning the uterine lining.

Most POPs feature low daily doses of hormones like levonorgestrel, norethindrone, or 75 μg desogestrel. A standout option is the drospirenone-only pill (sold as Slynd), which follows a 28-day cycle: 24 days of 4 mg drospirenone followed by 4 placebo days. This formulation includes the same progestin found in Yaz and Yasmin and is known for its anti-androgenic properties. Let’s explore how POPs impact weight, metabolic health, and androgenic symptoms in PCOS.

Effects on Weight/BMI

POPs are generally considered weight-neutral for women with PCOS. Studies show that users typically gain less than 2 kg (4.4 lb) over a 6–12 month period. This minimal weight change makes them a practical option for women managing PCOS-related weight concerns.

However, there’s a cautionary note for individuals with obesity: standard POPs may be less effective as contraceptives in this group. In such cases, healthcare providers might suggest taking two POPs daily or exploring alternatives like the etonogestrel implant or levonorgestrel IUD.

Androgenic Symptom Control

Managing androgenic symptoms, such as acne and excessive facial hair, is a priority for many women with PCOS. Unfortunately, most POPs are not particularly effective at addressing these issues. Progestin-only contraception generally has limited impact on hyperandrogenism, with one key exception: the drospirenone-only pill.

Drospirenone stands out for its strong anti-androgenic properties, making it more effective in treating PCOS-related symptoms like hirsutism and acne. When compared to other progestins like cyproterone acetate and desogestrel, drospirenone often delivers similar or better results. For patients who experience persistent androgen excess with standard POPs or cannot take estrogen due to health risks, combining progestin-only contraception with anti-androgen medications may provide better symptom relief.

Suitability for Metabolic Risk Profiles

POPs are particularly well-suited for women with PCOS who face significant metabolic or cardiovascular risks. They are considered safe for patients with conditions like coronary artery disease, cerebrovascular disease, venous thromboembolism, or hypertension.

Research shows that POPs do not significantly increase the risk of venous thromboembolism compared to non-hormonal contraceptives. This makes them an excellent choice for PCOS patients, who often have elevated cardiovascular risks.

POPs also have minimal impact on carbohydrate metabolism, making them a good option for women with PCOS. The drospirenone formulation goes a step further by actively influencing hormones, insulin, and lipid metabolism, offering additional benefits for managing PCOS symptoms.

Common Side Effects

Irregular bleeding and benign follicular cysts are among the most common side effects of POPs. Breakthrough bleeding occurs more frequently with POPs than with combined oral contraceptives.

Another potential side effect is an increased likelihood of follicular cysts, which are typically harmless and resolve on their own. Additionally, POPs require strict daily timing for effectiveness.

For women with PCOS who also have insulin resistance, obesity, or a high LH/FSH ratio, combining drospirenone with metformin can be more effective than drospirenone alone. However, this combination requires careful medical supervision to manage potential interactions and side effects.

sbb-itb-6dba428

4. Third-Generation Combined Oral Contraceptive Pills (COCPs)

Third-generation COCPs are designed to minimize androgenic activity, making them a suitable choice for managing both hormone imbalances and weight concerns in women with PCOS. These pills typically combine ethinylestradiol with progestins like desogestrel or gestodene, which have low androgenic activity. They work by suppressing luteinizing hormone (LH) levels to reduce ovarian androgen production and increasing sex hormone-binding globulin (SHBG) to lower free androgen concentrations.

Effects on Weight/BMI

One common concern with contraceptive pills is their impact on weight. However, research shows that third-generation COCPs are largely weight-neutral. A systematic review found no significant changes in BMI among women using these formulations compared to those who did not. Although the certainty of this evidence is considered very low, the findings are reassuring for those worried about weight gain. In addition to being weight-neutral, these pills offer added benefits in managing androgenic symptoms.

Androgenic Symptom Control

Third-generation COCPs are particularly effective in addressing androgenic symptoms like acne and excessive hair growth. Thanks to their lower androgenic activity, they are less likely to exacerbate these issues compared to older formulations. Improvements in hirsutism typically require at least six months of consistent use, while acne often shows improvement more quickly. A 2012 Cochrane meta-analysis, which included 31 trials and over 12,500 women, confirmed that COCPs significantly reduced acne in nearly all participants when compared to placebo. These benefits make third-generation COCPs a valuable option for managing both skin and hair-related symptoms.

Suitability for Metabolic Risk Profiles

Beyond hormonal and androgenic symptom management, third-generation COCPs also demonstrate a relatively neutral impact on metabolic health. For example, combinations of ethinylestradiol and norgestimate have minimal effects on carbohydrate metabolism and do not cause significant changes in body weight. While they may slightly increase HDL, LDL, and triglyceride levels over time, they have no notable effects on fasting blood glucose, insulin levels, or blood pressure. When choosing a COCP, it's important to consider individual factors such as weight, menstrual irregularities, signs of hyperandrogenism, and any existing metabolic concerns.

Common Side Effects

Third-generation COCPs generally come with a mild side effect profile. Some users may experience fluid retention, and monitoring cholesterol and triglyceride levels during the first year of use is often recommended. Ultimately, selecting the most appropriate COCP depends on individual needs, including body weight, menstrual cycles, androgenic symptoms, and metabolic health.

Pros and Cons

When choosing a birth control method for managing PCOS, it’s essential to weigh the benefits and drawbacks of each option against your specific symptoms and health profile.

Fourth-generation COCPs are well-known for their anti-androgenic properties. Drospirenone, a key component, helps reduce water retention and bloating due to its anti-androgenic and antimineralocorticoid effects. These pills can also increase HDL cholesterol, which may be beneficial for women with PCOS and obesity. However, they come with a downside - a 58% higher risk of venous thromboembolism (VTE) compared to levonorgestrel-based pills.

Ethinyl estradiol/cyproterone acetate (EE/CPA) combinations are particularly effective for managing severe hirsutism and acne, thanks to their strong anti-androgenic effects. That said, these formulations carry a significant risk of VTE, with a risk ratio of 2.04 compared to levonorgestrel. This makes them less suitable for women with mild hyperandrogenism or those at higher risk for blood clots.

Progestin-only pills (POPs) are a good alternative for women who can’t use estrogen-containing contraceptives. They generally have fewer side effects and avoid estrogen-related risks like blood clots. However, apart from drospirenone-only formulations, POPs don’t offer much help with acne or other androgenic symptoms.

Third-generation COCPs are often weight-neutral and can help improve acne and hirsutism. Studies show these pills don’t significantly affect body mass index and have minimal impact on metabolic health.

Here’s a quick comparison of the key features:

The choice of birth control should align with your unique metabolic profile and the severity of your symptoms. For women who are overweight, obese, or concerned about glucose tolerance, options like drospirenone or dienogest-containing formulations may be more suitable due to their minimal metabolic effects.

It’s worth noting that 40–85% of women with PCOS are overweight or obese, and the use of combined oral contraceptives has decreased by over 20% in the last decade. Selecting the right option can help address both hormonal and metabolic concerns effectively.

Personalized Treatment Options for PCOS

Managing PCOS requires a tailored approach. As Dr. Lee Radosh explains:

"PCOS is not a simple complex condition for which one treatment addresses all manifestations... physicians must individualize treatment goals and target treatment to specific manifestations".

This means that effective care involves addressing both hormonal and metabolic concerns through a personalized evaluation.

A comprehensive review of your medical history is essential. This includes assessing cardiometabolic risks like hypertension, high cholesterol, glucose intolerance, and diabetes. Baseline measurements - such as BMI, waist circumference, blood pressure, and hirsutism score - along with blood tests like an oral glucose tolerance test and lipid profile, provide the foundation for creating a tailored treatment plan. From there, treatments can include hormonal therapies, medications, and lifestyle adjustments.

For many women, managing insulin resistance goes beyond birth control. GLP-1 agonists, such as Ozempic and semaglutide, are showing significant promise in treating PCOS. These medications often perform better than metformin for weight loss and improving insulin sensitivity. For example, a study found that semaglutide helped obese PCOS patients lose an average of 16.7 pounds over six months when lifestyle changes alone hadn’t worked. Another study revealed that liraglutide, another GLP-1 agonist, lowered free testosterone levels by 19% after six months. Even modest weight loss - 5–10% of body weight - can lead to noticeable improvements in PCOS symptoms.

The Role of Telehealth in Personalized PCOS Care

Telehealth has transformed access to PCOS care, especially for the 19 million people in the U.S. living in contraceptive deserts. These platforms offer personalized care based on your medical history, making specialized treatment more accessible.

Oana Health, for instance, focuses on telehealth solutions for PCOS. Their licensed professionals prescribe treatments for insulin resistance, weight management, acne, hair loss, unwanted facial hair, and even mental health concerns. Medications are delivered straight to your door with free shipping. Some of their offerings include:

• Metformin for insulin resistance (starting at $22/month)
• Oral GLP-1 medications like semaglutide for advanced insulin sensitivity ($199/month)
• Spironolactone for unwanted hair growth ($14/month)
• Topical treatments, which may have fewer side effects compared to oral options

As registered dietitian Brooke Miner highlights:

"Ozempic may help manage PCOS as it effectively lowers blood sugar and improves insulin sensitivity. In PCOS, this can support better metabolic control, induce weight loss, regulate cycles, and reduce androgen-driven symptoms".

Comprehensive Lifestyle Support

Telehealth services also simplify access to ongoing lifestyle guidance. Effective PCOS management blends targeted treatments with sustainable lifestyle changes. This includes a diet rich in protein, fiber, and healthy fats, regular exercise (both cardio and strength training), stress management, and prioritizing quality sleep.

Brooke Miner, RD, underscores the importance of consistency:

"Focus on regular, balanced habits rather than perfection - consistent meal timing and stable dietary choices keep blood sugar and energy levels steady".

In 2023, the American Society for Reproductive Medicine recognized GLP-1 medications as part of its PCOS management guidelines for weight management. Medically managed weight loss programs can help regulate menstrual cycles, improve overall PCOS symptoms, and lower the risks of diabetes and hypertension. Additionally, a study published in the New England Journal of Medicine showed that lifestyle interventions, including weight loss, can reduce the risk of developing type 2 diabetes by 58%.

Conclusion

Finding the right birth control for managing PCOS and weight requires a personalized approach. For those looking for hormonal balance with minimal impact on weight, fourth-generation combined oral contraceptive pills (COCPs) containing drospirenone are a reliable option. Meanwhile, ethinyl estradiol/cyproterone acetate offers strong anti-androgen benefits, making it effective for addressing severe symptoms. For women who need to avoid estrogen, progestin-only pills are a solid alternative, while third-generation COCPs provide a balance between symptom control and metabolic safety. Each option demonstrates how hormonal formulations can help manage PCOS symptoms while considering weight-related concerns.

Your health profile, metabolic risks, and specific PCOS symptoms should guide your decision. Starting with baseline measurements - such as body mass index (BMI), waist circumference, and blood pressure - can help you make an informed choice tailored to your needs.

Pairing contraception with lifestyle changes offers a well-rounded approach to managing PCOS. If side effects occur, don’t hesitate to reach out to your healthcare provider to explore alternative methods. Finding the right fit might take some adjustments, but it’s worth the effort to align with your goals and overall health.

For a more personalized plan, combining expert guidance with lifestyle modifications is essential. Regular monitoring and professional advice ensure you select a method that not only manages PCOS symptoms but also supports your weight-related goals. To explore tailored treatment options and receive expert advice, consult the licensed professionals at Oana Health.

FAQs

What are the pros and cons of using fourth-generation birth control pills to manage PCOS symptoms?

Fourth-generation birth control pills are often used to help manage symptoms of PCOS. They can regulate menstrual cycles, lower testosterone levels, and reduce hyperandrogenic symptoms like acne and excess hair growth. These benefits make them a common choice for addressing hormonal imbalances tied to PCOS.

That said, there are some potential drawbacks. These pills can increase the risk of venous thromboembolism, may cause mood swings, and could lead to metabolic changes, including weight gain or shifts in cholesterol levels. Women with obesity or insulin resistance might face a higher likelihood of these side effects. It's crucial to consult with a healthcare provider to evaluate whether this option aligns with your specific health needs.

What are the differences between progestin-only pills and other birth control options for managing PCOS and weight concerns?

Progestin-only pills (POPs) are a dependable contraceptive choice for women with PCOS, especially for those concerned about weight gain. On average, weight gain with POPs tends to stay below 4 pounds, making them a lighter option in this regard. However, POPs might not be as effective as combined oral contraceptives (COCs) in managing menstrual irregularities or addressing common PCOS symptoms like acne and excess hair growth.

COCs are often the go-to option because they not only provide reliable birth control but also help tackle PCOS-related concerns more effectively. Still, POPs can be an excellent alternative for women who are sensitive to estrogen or want to keep weight gain to a minimum. To figure out which option suits you best, it’s crucial to talk with your healthcare provider about your individual needs and priorities.

What lifestyle changes can help manage PCOS symptoms and support weight control alongside birth control?

To help manage PCOS symptoms and maintain a healthy weight, adopting sustainable lifestyle habits can make a big difference. Start by aiming for at least 150 minutes of moderate exercise each week - activities like brisk walking, cycling, or strength training are great options. Combine this with a nutritious diet rich in fruits, vegetables, whole grains, lean proteins, and healthy fats. This approach not only supports blood sugar balance but also improves insulin sensitivity.

It's equally important to address other factors like stress management and ensuring you get 7–9 hours of quality sleep each night. Making small, consistent changes to your daily routine can complement hormonal treatments, improving overall well-being and helping to counteract the weight gain often linked to PCOS.

Related posts

• Metformin vs Birth Control for PCOS
• Oral Contraceptives for PCOS: Regulating Periods and More
• Managing PCOS with Extended-Cycle Contraceptives
• Oral Contraceptives for PCOS: Problem-Solution Guide